Resultados de la búsqueda 181-190 of 13897 for Teratogenic

  1. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    The overall objective of this study is to define genes causing cystic kidney disease and to determine the degree to which variants at these cystic kidney ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to collect adipose tissue from patients undergoing elective surgery, or from healthy volunteers, test the donors to assure that ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  4. Radiología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to learn more about the distribution of the pathological protein tau in the living brains of patients with Progressive Supranuclear ...

  5. Transplant Center de Mayo Clinic - Ensayos clínicos

    A Study to Explore Ghrelin Levels with Primary Graft Dysfunction in Lung Transplant Recipients ... Jacksonville, Fla. The purpose of this study is to investigate ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  7. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purposes of this study are (i) to obtain and study biospecimens from patients with breast cancer that has either spread out of the breast ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

  10. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...